NAFT-600

· Merz North America, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NAFT-600, covering 2013-09-26 to 2013-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis [Phase 3]